Collegium Pharmaceutical Files 2024 10-K
Ticker: COLL · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1267565
| Field | Detail |
|---|---|
| Company | Collegium Pharmaceutical, Inc (COLL) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals, share-repurchase
TL;DR
Collegium Pharma's 2024 10-K is in! Full financials and biz ops for the year ending Dec 31, 2024.
AI Summary
Collegium Pharmaceutical, Inc. filed its 2024 10-K on February 27, 2025, reporting on its fiscal year ending December 31, 2024. The company, based in Stoughton, MA, operates in the pharmaceutical preparations sector. The filing details financial performance and business operations for the period, including information on share repurchase programs and treasury stock transactions.
Why It Matters
This filing provides investors with a comprehensive overview of Collegium Pharmaceutical's financial health and strategic activities for the 2024 fiscal year, impacting investment decisions.
Risk Assessment
Risk Level: medium — The filing is a standard annual report and does not inherently indicate new or elevated risks.
Key Numbers
- 2024 — Fiscal Year (Reporting period covered by the 10-K)
- December 31, 2024 — Fiscal Year End (End date of the reporting period)
- February 27, 2025 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- COLLEGIUM PHARMACEUTICAL, INC (company) — Filer
- 0001558370-25-001801 (accession_number) — Filing identifier
- 20250227 (date) — Filing date
- 20241231 (date) — Fiscal year end
- STOUGHTON, MA (location) — Company headquarters
- 781-713-3699 (phone_number) — Company phone number
FAQ
What is the primary business of Collegium Pharmaceutical, Inc.?
Collegium Pharmaceutical, Inc. operates in the Pharmaceutical Preparations sector, as indicated by its SIC code [2834].
When was the 10-K filing submitted to the SEC?
The 10-K filing was submitted on February 27, 2025.
What is the fiscal year end for the period covered by this 10-K?
The fiscal year end for the period covered by this 10-K is December 31, 2024.
Where is Collegium Pharmaceutical, Inc. headquartered?
Collegium Pharmaceutical, Inc. is headquartered at 100 Technology Center Drive, Stoughton, MA 02072.
Does the filing mention any share repurchase programs?
Yes, the filing references several share repurchase programs, including an Accelerated Share Repurchase Program in May 2024 and November 2023, and a Share Repurchase Program for 2024-2025.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding COLLEGIUM PHARMACEUTICAL, INC (COLL).